Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000037138 | SCV000050815 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000037138 | SCV000060795 | benign | not specified | 2011-10-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000037138 | SCV000167535 | benign | not specified | 2012-04-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000253496 | SCV000318336 | benign | Cardiovascular phenotype | 2015-08-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000625056 | SCV000347687 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Invitae | RCV002513467 | SCV000559568 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000625056 | SCV000743632 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 2 | 2016-10-04 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625056 | SCV000744948 | benign | Catecholaminergic polymorphic ventricular tachycardia 2 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000768705 | SCV000900075 | benign | Cardiomyopathy | 2015-11-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000625056 | SCV004048974 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 2 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000037138 | SCV001922055 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000037138 | SCV001958446 | benign | not specified | no assertion criteria provided | clinical testing |